Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Sarfati

Showing results (51-60 of 59) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 59 results.
Bulletin De La Societe De Pathologie Exotique Et De Ses Filiales|January 1, 1989
[A study in the Ivory Coast (1985-1987) of the efficacy and tolerance of ivermectin (Mectizan) in human onchocerciasis. III. The tolerance and efficacy of a single oral dose of 150 mcg/kg in children]M Larivière, B Beauvais, M Aziz, et al.
Bulletin De La Societe De Pathologie Exotique Et De Ses Filiales|January 1, 1989
[A study in the Ivory Coast (1985-1987) of the efficacy and tolerance of ivermectin (Mectizan) in human onchocerciasis. I. A comparative double-blind study of 220 patients with onchocerciasis treated with a single oral dose of 100, 150 or 200 mcg/kg]M Larivière, B Beauvais, M Aziz, et al.
The Journal of Eukaryotic Microbiology|March 21, 1998
Detection of microsporidia and identification of Enterocytozoon bieneusi in surface water by filtration followed by specific PCRJ M Sparfel, C Sarfati, O Liguory, et al.
Methods of Information in Medicine|November 8, 2014
From adverse drug event detection to prevention. A novel clinical decision support framework for medication safetyV G Koutkias, P McNair, V Kilintzis, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 4, 2006
First case of cutaneous reconstitution inflammatory syndrome associated with HIV infection and leishmaniasisD Kérob, J D Bouaziz, C Sarfati, et al.
AIDS (London, England)|August 10, 2000
Trial of oral fumagillin for the treatment of intestinal microsporidiosis in patients with HIV infection. ANRS 054 Study Group. Agence Nationale de Recherche sur le SIDAJ M Molina, J Goguel, C Sarfati, et al.
AIDS (London, England)|November 20, 1997
Potential efficacy of fumagillin in intestinal microsporidiosis due to Enterocytozoon bieneusi in patients with HIV infection: results of a drug screening study. The French Microsporidiosis Study GroupJ M Molina, J Goguel, C Sarfati, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|September 23, 2008
Microsporidiosis in solid organ transplant recipients: two Enterocytozoon bieneusi cases and reviewF Lanternier, D Boutboul, J Menotti, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|January 14, 2011
Pneumocystosis: a network survey in the Paris area 2003-2008D Magne, A Angoulvant, F Botterel, et al.
Pageof 6

Showing results (51-60 of 59) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
Bulletin De La Societe De Pathologie Exotique Et De Ses Filiales|January 1, 1989
[A study in the Ivory Coast (1985-1987) of the efficacy and tolerance of ivermectin (Mectizan) in human onchocerciasis. III. The tolerance and efficacy of a single oral dose of 150 mcg/kg in children]M Larivière, B Beauvais, M Aziz, et al.
Bulletin De La Societe De Pathologie Exotique Et De Ses Filiales|January 1, 1989
[A study in the Ivory Coast (1985-1987) of the efficacy and tolerance of ivermectin (Mectizan) in human onchocerciasis. I. A comparative double-blind study of 220 patients with onchocerciasis treated with a single oral dose of 100, 150 or 200 mcg/kg]M Larivière, B Beauvais, M Aziz, et al.
The Journal of Eukaryotic Microbiology|March 21, 1998
Detection of microsporidia and identification of Enterocytozoon bieneusi in surface water by filtration followed by specific PCRJ M Sparfel, C Sarfati, O Liguory, et al.
Methods of Information in Medicine|November 8, 2014
From adverse drug event detection to prevention. A novel clinical decision support framework for medication safetyV G Koutkias, P McNair, V Kilintzis, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 4, 2006
First case of cutaneous reconstitution inflammatory syndrome associated with HIV infection and leishmaniasisD Kérob, J D Bouaziz, C Sarfati, et al.
AIDS (London, England)|August 10, 2000
Trial of oral fumagillin for the treatment of intestinal microsporidiosis in patients with HIV infection. ANRS 054 Study Group. Agence Nationale de Recherche sur le SIDAJ M Molina, J Goguel, C Sarfati, et al.
AIDS (London, England)|November 20, 1997
Potential efficacy of fumagillin in intestinal microsporidiosis due to Enterocytozoon bieneusi in patients with HIV infection: results of a drug screening study. The French Microsporidiosis Study GroupJ M Molina, J Goguel, C Sarfati, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|September 23, 2008
Microsporidiosis in solid organ transplant recipients: two Enterocytozoon bieneusi cases and reviewF Lanternier, D Boutboul, J Menotti, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|January 14, 2011
Pneumocystosis: a network survey in the Paris area 2003-2008D Magne, A Angoulvant, F Botterel, et al.
Pageof 6